Early-life respiratory infections: diagnosis, prognosis and treatment

D. Bogaert (Edinburgh, United Kingdom)

Source: International Congress 2019 – Early origins of lung disease: an interdisciplinary approach
Session: Early origins of lung disease: an interdisciplinary approach
Session type: Symposium
Number: 445
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Bogaert (Edinburgh, United Kingdom). Early-life respiratory infections: diagnosis, prognosis and treatment. International Congress 2019 – Early origins of lung disease: an interdisciplinary approach

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment
Source: Eur Respir Rev, 29 (157) 200038; 10.1183/16000617.0038-2020
Year: 2020



Current treatments for respiratory infections in children
Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children
Year: 2005


Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011



Lower respiratory tract infections: diagnosis and treatment in clinical practice
Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice"
Year: 2014

Epidemiology and prognosis of acute respiratory distress syndrome
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=1
Year: 2002

Age-related pattern of childhood lung infection and its complications
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=189
Year: 2002

Epidemiology of respiratory infection in children
Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children
Year: 2005


Do childhood respiratory infections continue to influence adult respiratory morbidity?
Source: Eur Respir J 2009; 33: 237-244
Year: 2009



Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections
Source: Eur Respir J, 51 (3) 1701656; 10.1183/13993003.01656-2017
Year: 2018



Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients
Source: Eur Respir J 2001; 17: 87-93
Year: 2001



Clinical management of children with recurrent respiratory infections
Source: International Congress 2016 – PG9 Recurrent respiratory infections in both children and adults
Year: 2016



Long-term respiratory consequences of childhood cancer and its treatment
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=267
Year: 2002

Recurrent respiratory infections in Georgian children: etiology and immunological status
Source: Eur Respir J 2004; 24: Suppl. 48, 393s
Year: 2004

Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Early-life respiratory tract infections and the risk of lower lung function and asthma:a meta-analysis of 154,492 children.
Source: International Congress 2017 – Determinants of childhood asthma and atopy
Year: 2017



School children as change agent for early diagnosis, treatment and prevention of respiratory illness and diseases
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020

Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013



Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021